CYP7A1 and cardiovascular disorder: Nonetheless, data from genome-wide association studies showed that both polymorphisms located downstream of the CYP7A1 enhancer region could impact LDL–C and total cholesterol plasma levels and that they were potentially associated with cardiovascular diseases [27,28,29,30].